In a joint letter published today, the European Commission, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) reminded all sponsors of clinical trials conducted in the European Union of their obligation to make summaries of results of concluded trials publicly available in the EU Clinical Trials Database.
Related Documents
Details
- Publication date
- 3 July 2019
- Author
- Directorate-General for Health and Food Safety